Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
EuroIntervention 2014;9:1271-1284 published online ahead of print December 2013. DOI: 10.4244/EIJV9I11A217
Patrick W. Serruys1*, MD, PhD; Yoshinobu Onuma1, MD; Hector M. Garcia-Garcia1,15, MD, PhD; Takashi Muramatsu1, MD, PhD; Robert-Jan van Geuns1, MD, PhD; Bernard de Bruyne2, MD, PhD; Dariusz Dudek3, MD; Leif Thuesen4, MD; Pieter C. Smits5, MD, PhD; Bernard Chevalier6, MD; Dougal McClean7, MD; Jacques Koolen8, MD, PhD; Stephan Windecker9, MD; Robert Whitbourn10, MD; Ian Meredith11, MD, PhD; Cecile Dorange12, MSc; Susan Veldhof12, RN; Karine Miquel Hebert12, P
1. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Cardiovascular Center, Aalst, Belgium; 3. Jagiellonian University, Krakow, Poland; 4. Skejby Sygehus University Hospital, Aarhus, Denmark; 5. Maasstad Hospital, Rotterdam, The Netherl
Aims: To assess observations with multimodality imaging of the Absorb bioresorbable everolimus-eluting vascular scaffold performed in two consecutive cohorts of patients who were serially